Live Breaking News & Updates on Centre For Immunology|Page 4

Stay updated with breaking news from Centre for immunology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New study reveals oral opaganib's potent in vitro activity against Omicron

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced study results in which opaganib (ABC294640), a leading oral drug candidate for hospitalized patients with moderate to severe COVID-19, was observed to have potent in vitro efficacy against the Omicron SARS-CoV-2 variant, while maintaining host cell viability. ....

North Somerset , United Kingdom , Michael Chan , Reza Fathi , Emily Henderson , Us National Institute Of Health , Centre For Immunology , University Of Hong Kong , School Of Public Health , Redhill Biopharma Ltd , Hill Biopharma , Hong Kong , Public Health , Principal Investigator , Hazard Ratio , Orphan Drug , Covid 19 , N Vitro , Anti Inflammatory , Nex Vivo , Infectious Diseases , Opioid Induced Constipation , Prostate Cancer , Public Health , Ars Cov 2 , Spike Protein ,